Clinical trial
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of…
NCT00395395 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00395395 |
|---|---|
| Title | Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women |
| Official title | A Partially-Blind, Randomized, Single-Dose, Placebo-Controlled Crossover Phase I Study Assessing the Effect of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of SMC021 0.8 mg in Healthy Postmenopausal Women |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | Oral salmon calcitonin, salmon calcitonin nasal spray |
| Enrollment | 56 |
| Start date | Oct 1, 2006 |
| First posted | Nov 2, 2006 |
| Last update posted | May 28, 2007 |
| Countries | Denmark |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: